Willow vs Hims: Compare GLP-1 Programs & Pricing
Side-by-side Willow and Hims: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
Willow and Hims are telehealth platforms that offer access to GLP-1–based therapies and related clinical support. This comparison focuses on pricing transparency, medical process, safety considerations, and user experience to help you decide which service may suit your needs. Neither platform replaces in-person care; both rely on clinician evaluation via telehealth.
Willow vs Hims: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| Willow | $299.00 | $399.00 | Best for Oral and Injectable | No |
| Hims | — | — | — | — |
Willow vs Hims: Medical Process & Accessibility
Both providers use licensed clinicians to evaluate patients remotely. Typical steps include an online intake, medical history review, and clinician determination of suitability for GLP-1 therapy. If a clinician approves treatment, prescriptions are filled by partner pharmacies and shipped to the patient. Telehealth evaluation is required and clinicians may decline therapy based on contraindications or safety concerns.
Willow emphasizes fast onboarding and accessible pricing, while Hims is known for structured follow-ups and integrated care pathways for ongoing dose adjustments. Availability, prescribing rules, and follow-up frequency depend on the clinician and state regulations.
Willow vs Hims: Pricing Comparison
Willow lists semaglutide starting at $299.00 and tirzepatide at $399.00. Hims does not publish a comparable starting price in the data provided here. Because Hims’s listed pricing isn’t available in this comparison, Willow’s public starting prices are shown to help shoppers estimate first-month costs. Always confirm current pricing directly on each provider’s website before enrolling.
Promotions and membership requirements vary: Willow is noted here as “Best for Oral and Injectable” and does not require a membership fee. Hims may offer different plans or membership-based discounts; check Hims directly for up-to-date promotions. Factor in refill prices, clinician follow-ups, and shipping when comparing total cost over time.
Willow vs Hims: Clinical Oversight & Support
Both platforms provide clinician oversight: licensed prescribers review health history, contraindications, and potential drug interactions before approving GLP-1 therapy. Follow-up schedules vary; some patients receive routine check-ins to adjust dosing and monitor side effects.
Willow vs Hims: Medication Quality & Safety
Medications offered through telehealth services may include compounded GLP-1 formulations dispensed by U.S. pharmacies. These compounds are not identical to FDA-approved branded products (for example, Wegovy® or Mounjaro®) and should be prescribed only after a clinician’s assessment. Patients with a history of pancreatitis, certain thyroid conditions, pregnancy, or other contraindications should not use GLP-1s unless directed by a clinician. Always follow prescriber instructions and report adverse effects promptly.
Willow vs Hims: Customer Experience
User feedback often highlights Willow for quick onboarding and price transparency, while Hims receives praise for structured support and ongoing care coordination. Shipping timelines, pharmacy partners, and refill processes can affect the overall experience; verify these logistics before signing up.
Willow vs Hims: Final Verdict
If low published starting cost and rapid access are your priorities, Willow may be the practical choice based on the available pricing here. If you prioritize more formalized follow-up and integrated care features, Hims may better match those needs — but confirm current pricing and program details directly with Hims before enrolling. Both services require clinician approval and adhere to telehealth standards for prescribing controlled and non-controlled medications.
Join Willow
Get Started with Hims
Disclaimer
This article is informational only and does not constitute medical advice. Always consult a licensed clinician before starting or changing any medication. Pricing and program details were correct at the time of publication but are subject to change; confirm details with each provider. ExploreProviders / GLP1Talks may receive affiliate compensation for links on this page.